These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10365016)

  • 1. Malignant hyperpyrexic syndrome.
    Hall LW
    Br J Anaesth; 1999 Feb; 82(2):299. PubMed ID: 10365016
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. 1975.
    Harrison GG
    Br J Anaesth; 1998 Oct; 81(4):626-9; discussion 625. PubMed ID: 9924249
    [No Abstract]   [Full Text] [Related]  

  • 3. Early Development, Identification of Mode of Action, and Use of Dantrolene Sodium: The Role of Keith Ellis, Ph.D.
    Pollock NA; Machon RG; Rosenberg H
    Anesthesiology; 2017 May; 126(5):774-779. PubMed ID: 28272142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
    Harrison GG
    Br J Anaesth; 1975 Jan; 47(1):62-5. PubMed ID: 1148076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clodanolene sodium and malignant hyperpyrexia.
    Sullivan JS; Galloway GJ; Denborough MA
    Br J Anaesth; 1982 Nov; 54(11):1237. PubMed ID: 7138728
    [No Abstract]   [Full Text] [Related]  

  • 7. Ryanodex--A New Dantrolene Formulation for Malignant Hyperthermia.
    Med Lett Drugs Ther; 2015 Jul; 57(1472):100. PubMed ID: 26147894
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.
    Palnitkar SS; Mickelson JR; Louis CF; Parness J
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):847-52. PubMed ID: 9307036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The history of malignant hyperthermia].
    Jantzen JP; Kaufmann-Stemp D
    Cah Anesthesiol; 1991; 39(7):505-8. PubMed ID: 1797362
    [No Abstract]   [Full Text] [Related]  

  • 11. Mixing and using dantrolene for simulated malignant hyperthermia crisis.
    Corvetto MA; Montaña R; Bravo MP; Altermatt FR
    Acta Anaesthesiol Scand; 2012 Nov; 56(10):1337-8. PubMed ID: 22881345
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant hyperthermia in the early days of pediatric anesthesia: an interview with anesthesiology pioneer, Dr. John F. Ryan.
    King MR; Firth PG; Yaster M; Ahmed Z; Mai CL
    Paediatr Anaesth; 2015 Sep; 25(9):871-6. PubMed ID: 26036863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia. 1962.
    Denborough MA
    Anesthesiology; 2008 Jan; 108(1):156-7. PubMed ID: 18156894
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant hyperthermia.
    Heggie J
    Can J Anaesth; 1999 Sep; 46(9):910. PubMed ID: 10490170
    [No Abstract]   [Full Text] [Related]  

  • 15. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia: presymptomatic screening and treatment 2011.
    Urwyler A
    Eur J Anaesthesiol; 2011 Apr; 28(4):237-9. PubMed ID: 21389807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant hyperthermia. History of a serious complication after general anesthesia].
    Appelgren LK
    Lakartidningen; 1997 Feb; 94(7):534, 539-44. PubMed ID: 9064458
    [No Abstract]   [Full Text] [Related]  

  • 18. Dantrolene preparation.
    Russell T; Steel A
    Anaesth Intensive Care; 2011 Nov; 39(6):1150; author reply 1150-1. PubMed ID: 22165375
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
    Magistris F; Gamble J
    A A Case Rep; 2017 Nov; 9(9):251-253. PubMed ID: 28697029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia and compartment syndrome.
    Steele AP; Imrie MM; Rutherford AM; Bradley WN
    Br J Anaesth; 1995 Sep; 75(3):369. PubMed ID: 7547062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.